<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00933257</url>
  </required_header>
  <id_info>
    <org_study_id>LACAC_L_04808</org_study_id>
    <nct_id>NCT00933257</nct_id>
  </id_info>
  <brief_title>Dermacyd PH_DESILSTY_FR (Lactic Acid) - Photo Evaluation - Stay on Frutal</brief_title>
  <official_title>Study Title: Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd PH_DESILSTY_FR.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sanofi</source>
  <brief_summary>
    <textblock>
      Primary Objective:

      To demonstrate the absence of photoirritation and potential photosensitization of the product
      Dermacyd PHDESILSTYFR.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measure of the photo irritation test and the photosensitivity byusing UVA irradiation and evaluation according to International Contact Dermatitis Research Group (ICDRG) scale. Evaluation of the sensibility according to the skin type.</measure>
    <time_frame>From the treatment start to the end of the study (treatment period 5 weeks)</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Hygiene</condition>
  <arm_group>
    <arm_group_label>Dermacyd PH_DESILSTY_FR (Lactic Acid)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dermacyd PH_DESILSTY_FR (Lactic Acid) sample will be applied like a curative. Physiologic solution and mineral oil will be also used as a control sample.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LACTIC ACID(ND)</intervention_name>
    <description>Treatment duration 5 weeks</description>
    <arm_group_label>Dermacyd PH_DESILSTY_FR (Lactic Acid)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Phototype Skin II and III Integral skin test in the region

          -  Willingness in following the study procedures and to be present in the clinic at the
             days and scheduled time for medical evaluations and for application of occlusion

        Exclusion criteria:

          -  Lactation or pregnancy

          -  Use of Antiinflammatory 30 days and/or immunossupression drugs until 3 months before
             volunteers selection

          -  Disease which can cause immunosuppresion, such as diabetes, HIV

          -  Concomitant use of photosensitivity drugs

          -  History of sensitivity or photosensitivity with topic products

          -  Cutaneous active disease which can modify the study results

          -  History or activity of photodermatosis

          -  Personal or family antecedents of cutaneous neoplasia photo induced

          -  Presence of injury precursor of cutaneous neoplasia, such as melanociticos nevus and
             actinic keratosis

          -  Intense exposure solar in the test region

          -  Use of new drugs and/or cosmetics during the study

          -  Previous participation in studies using the same product in test

          -  Relevant history or confirmation of alcohol or other drugs abuse

          -  Intolerance detected or suspected for some component of the sample tested

          -  Medecin or sponsor employees or their close family.

        The above information is not intended to contain all considerations relevant to a patient's
        potential participation in a clinical trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jaderson Lima</last_name>
    <role>Study Director</role>
    <affiliation>Sanofi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 3, 2009</study_first_submitted>
  <study_first_submitted_qc>July 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2009</study_first_posted>
  <last_update_submitted>September 13, 2010</last_update_submitted>
  <last_update_submitted_qc>September 13, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2010</last_update_posted>
  <responsible_party>
    <name_title>Medical Affairs Study Director</name_title>
    <organization>sanofi-aventis</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

